You searched for "retinovascular"
Specialist high-street eye clinics for managing patients with retinal disorders can enhance care standards
The author examines the successful introduction of community-based retinal clinic services by Manchester University NHS Foundation Trust. Dr Sajjad Mahmood, Consultant Ophthalmologist, MREH, shares experience of establishing community-based medical retina clinic services. Sight loss from age-related macular degeneration (AMD), cataract,...RNIB launches new campaign to dispel myths and encourage people to ‘See the person, not the sight loss’
Leading sight loss charity RNIB (Royal National Institute of Blind People) and The&Partnership has today (3 October 2022) launched a new campaign ‘See the person, not the sight loss’, challenging outdated public attitudes and misperceptions of sight loss.Heidelberg Engineering’s Tosh Vadhia announced as new ambassador for Orbis UK
Tosh Vadhia, Head of Global Accounts at Heidelberg Engineering joins blindness prevention charity Orbis to help raise awareness of avoidable sight loss. Through Tosh Vadhia’s support, Heidelberg Engineering has played a key role in supporting Orbis’s mission to end avoidable...My Top Five: Innovations in the diagnosis of ocular tumours
Ocular tumours can vary widely in origin, from benign growths to metastases from distant disseminated malignancies. Although rare, ocular tumours pose a significant health and economic burden globally, with ocular cancers accounting for 0.2% of all diagnosed malignancies in the...Poppers retinopathy: What is it and how do we treat it?
Poppers retinopathy is a relatively unknown phenomenon which afflicts users of poppers but should be considered as a differential in sudden-onset or sub-acute visual acuity loss – particularly in patients with a history of recreational drug use. Raising awareness of...Non-arteritic anterior ischaemic optic neuropathy (NA-AION): a review
Ischaemic optic neuropathy (ION) is the commonest adult optic neuropathy encountered today in our ageing population, is a common cause of irreversible visual loss and is usually associated with underlying vascular disease. The condition is classified as follows: (a) Anterior...Addressing diabetes-related complications in Tanzania and Eswatini: A comprehensive approach to eye and foot screening
Diabetes is rising globally, particularly in low- to middle-income countries (LMICs), where healthcare systems are under resourced [1,2]. Among its complications, diabetic retinopathy (DR) and diabetic foot disease are preventable yet frequently overlooked [3-6]. These problems often develop together due...
Assessment of slow and fast vergence in stroke survivors
The authors present the findings of a prospective cohort study. Three hundred and five stroke survivors were recruited consecutively. The following exclusion criteria were applied; aphasia, cognitive impairment, visual inattention, ocular motor nerve palsy and neuromuscular disease. Fifty age-matched controls...
Assaying acetylcholine receptor antibodies in the diagnosis of ocular myasthenia
Myasthenia gravis (MG) is an autoimmune disease that leads to impaired neuromuscular transmission. Solely ocular manifestations of MG (OMG) occur in 15-50% of cases, most frequently in the form of fluctuating ptosis and diplopia. Most cases of OMG convert later...Moorfields: Vitreoretinal emergencies: A practical guide for health care professionals
Vitreoretinal emergencies: A practical guide for health care professionals
Insights in resistant diabetic macular oedema
This article gives a bird’s eye review of the different modalities for the treatment of diabetic macular oedema (DME). The debut of anti-VEGFs has brought a paradigm shift in DME management. This treatment has now become a major breakthrough in...
